Rising costs, regulatory quagmire make medical future uncertain

Dec. 1, 2004

By Holland Johnson

Cardio innovation in the clinical setting is explored at conference

Dec. 1, 2004

By Holland Johnson

Vitex Stock Falls On Enrollment Suspension In Inactine Phase III

Nov. 29, 2004

By Holland Johnson

Vitex Stock Falls On Enrollment Suspension In Inactine Phase III

Nov. 29, 2004

By Holland Johnson

GE Healthcare calls its Vivid i 'the virtual stethoscope of future'

Oct. 1, 2004

By Holland Johnson

Abbott enrolls first patient in study of its ZoMaxx DES

Oct. 1, 2004

By Holland Johnson

ReValving may change valve replacement and open-heart surgery

Aug. 1, 2004

By Holland Johnson

St. Jude becomes third company with entry in U.S. CRT-D market

Aug. 1, 2004

By Holland Johnson

Medtronic, Genzyme form j-v for cardio disease therapies

July 1, 2004

By Holland Johnson

Two firms' cardiac diagnostic tests are cleared for sale by FDA

June 1, 2004

By Holland Johnson